Cantor Fitzgerald hires Pamela Bassett as life sciences equity research analyst

By Angela McDaniels

Seattle, April 18 - Cantor Fitzgerald & Co. said Pamela Bassett has joined the firm's New York office as an equity research analyst covering the life sciences sector. Bassett will publish research on biotechnology, pharmaceutical, medical device and diagnostics companies.

Bassett has published extensively on emerging technologies and business strategies in biopharmaceuticals and has provided advisory services to technology companies on new product and emerging market development, according to a company news release.

Prior to joining Cantor Fitzgerald, Bassett was the founder and president of BioTrend Corp. and Stat Systems Inc. She was also director of business development for Enzon.

Bassett received a doctorate in dental medicine from Tufts University, a master's degree in business administration from the University of Pennsylvania and a bachelor's degree in biology from Oakland University.

Cantor Fitzgerald is based in New York and provides financial services to the institutional equity and fixed-income markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.